After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his pharmaceutical company. By Richard Sandomir Months ago, Mr. Icahn ...
NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX) today issued the following statement in response to a letter it received from Carl C. Icahn: “We are not surprised by Mr. Icahn’s ...
After New York City-based Forest Laboratories paid $313 million to settle a fraud case last year, the drugmaker’s chairman and CEO is now facing a ban from doing business with federal health programs, ...
NEW YORK-- (BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that reported earnings per share equaled $0.90 in the ...
Forest Laboratories, Inc. FRX (“Forest”) today announced that its Board of Directors has sent a letter to all Forest shareholders in connection with the Company's Annual Meeting on August 15, 2012.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results